Are current screening protocols for chronic hepatitis B virus infection adequate?

Diagnostic Microbiology and Infectious Disease

Volumn 85, Issue 2, 2016, Pages 159-167

  Mortensen, Eva ^a,b   Kamali, Amanda ^a,b   Schirmer, Patricia L ^c   Lucero Obusan, Cynthia ^c   Winston, Carla A ^a   Oda, Gina ^c   Winters, Mark A ^a,b   Durfee, Janet ^c   Martinello, Richard A ^c,d   Davey, Victoria J ^c   Holodniy, Mark ^a,b,c  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epidemiology; Hepatitis B virus (HBV); Review; Serology; Veterans

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B ANTIBODY; VIRUS DNA;

ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD SAMPLING; DISEASE TRANSMISSION; ENZYME IMMUNOASSAY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; SEROLOGY; VETERAN; VIRUS DETECTION; BLOOD; DIAGNOSTIC TEST; HEALTH SERVICES RESEARCH; HEPATITIS B, CHRONIC; MASS SCREENING; PROCEDURES; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

DIAGNOSTIC TESTS, ROUTINE; DNA, VIRAL; HEALTH SERVICES RESEARCH; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; MASS SCREENING; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84961275659     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2015.12.005     Document Type: Article

References (173)

1. Adachi H., et al. Clearance of HBsAg in seven patients with chronic hepatitis B. Hepatology 1992, 16(6):1334-1337.
2. Agency for Healthcare Research and Quality Screening for hepatitis B virus infection in nonpregnant adolescents and adults: Systematic Review to Update the 2004 U.S. Preventive Services Task Force Recommendation, U.S. Department of Health and Human Services; 2014. Report No.: 12-05172-EF-1 Available at. http://www.ncbi.nlm.nih.gov/books/NBK208504/.
3. Aghakhani A., et al. Occult hepatitis B virus infection in hemodialysis patients with isolated hepatitis B core antibody: a multicenter study. Ther Apher Dial 2010, 14(3):349-353.
4. Allain J.P., et al. Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion. Br J Haematol 1999, 107(1):186-195.
5. Allain J.P., Candotti D. Diagnostic algorithm for HBV safe transfusion. Blood Transfus 2009, 7(3):174-182.
6. Allice T., et al. COBAS AmpliPrep-COBAS TaqMan hepatitis B virus (HBV) test: a novel automated real-time PCR assay for quantification of HBV DNA in plasma. J Clin Microbiol 2007, 45(3):828-834.
7. Antar W., et al. Significance of detecting anti-HBc among Egyptian male blood donors negative for HBsAg. Transfus Med 2010, 20(6):409-413.
8. Arababadi M.K., Nasiri Ahmadabadi B., Kennedy D. Current information on the immunologic status of occult hepatitis B infection. Blood Transfus 2012, 52(8):1819-1826.
9. Arraes L.C., et al. The biological meaning of anti-HBC positive result in blood donors: relation to HBV-DNA and to other serological markers. Rev Inst Med Trop Sao Paulo 2003, 45(3):137-140.
10. Asim M., et al. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: implications for blood transfusion. Indian J Med Res 2010, 132:312-317.
11. Baker B.L., et al. Determination of hepatitis B virus DNA in serum using the polymerase chain reaction: clinical significance and correlation with serological and biochemical markers. Hepatology 1991, 13(4):632-636.
12. Behzad-Behbahani A., et al. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Indian J Med Res 2006, 123(1):37-42.
13. Bhatti F.A., et al. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Transfusion 2007, 47(1):74-79.
14. Bodhiphala P., et al. Detection of HBV genome by gene amplification method in HBsAg negative blood donors. J Med Assoc Thai 1999, 82(5):491-495.
15. Borentain P., et al. Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer. J Viral Hepat 2010, 17(11):807-815.
16. Bouike Y., et al. Infectivity of HBV DNA positive donations identified in look-back studies in Hyogo-Prefecture, Japan. Transfus Med 2011, 21(2):107-115.
17. Brechot C., et al. State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases. Proc Natl Acad Sci U S A 1981, 78(6):3906-3910.
18. Brechot C., et al. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med 1985, 312(5):270-276.
19. Burrell C.J., et al. Correlation between liver histology and markers of hepatitis B virus replication in infected patients: a study by in situ hybridization. Hepatology 1984, 4(1):20-24.
20. Caballero T., et al. Detection of hepatitis B virus in the liver by in situ hybridization (ISH) in HBsAg seropositive and seronegative patients. Histol Histopathol 1995, 10(2):265-270.
21. Cabrerizo M., et al. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. Hepatology 2000, 32(1):116-123.
22. Cabrerizo M., et al. Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen-negative hemodialysis patients and staff. J Am Soc Nephrol 1997, 8(9):1443-1447.
23. Carloni G., et al. Incidence of hepatitis B virus DNA and DNA-polymerase in sera of Italian asymptomatic carriers with the serological markers of HBV. Arch Virol 1986, 87(1-2):97-105.
24. Carloni G., et al. Detection of HBV infectivity by spot hybridization in HBeAg-negative chronic carriers: HBV DNA in sera from asymptomatic and symptomatic subjects. J Med Virol 1987, 21(1):15-23.
25. Carman W.F., et al. Incidence of hepatitis B viraemia, detected using the polymerase chain reaction, after successful therapy of hepatitis B virus carriers with interferon-alpha. J Med Virol 1991, 34(2):114-118.
26. Castillo I., et al. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection. J Med Virol 2007, 79(3):236-241.
27. Chaiteerakij R., et al. Intrahepatic HBV DNA and covalently closed circular DNA (cccDNA) levels in patients positive for anti-HBc and negative for HBsAg. Southeast Asian J Trop Med Public Health 2010, 41(4):867-875.
28. Chapel F., et al. PCR analysis of hepatitis B virus DNA in paraffin-embedded liver tissue from patients with chronic liver disease. Pathol Res Pract 1995, 191(10):961-966.
29. Chung H.T., Lai C.L., Lok A.S. Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis. Hepatology 1995, 22(1):25-29.
30. Coursaget P., et al. Detection of hepatitis B virus DNA by polymerase chain reaction in HBsAg negative Senegalese patients suffering from cirrhosis or primary liver cancer. FEMS Microbiol Lett 1991, 67(1):35-38.
31. Dazza M.C., et al. Population-based study of serum hepatitis B virus DNA in Gabon. Trans R Soc Trop Med Hyg 1993, 87(5):539-540.
32. De Feo T.M., et al. Risk of transmission of hepatitis B virus from anti-HBc positive cadaveric organ donors: a collaborative study. Transplant Proc 2005, 37(2):1238-1239.
33. Degos F., et al. Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients. A prospective study of 90 patients. Gastroenterology 1988, 94(1):151-156.
34. Dettke M., et al. Detection of HBV DNA-positive HBsAg-negative platelet concentrate by routine PCR screening. Transfusion 2001, 41(8):1074-1075.
35. Department of Vaccines and Biologicals Introduction of hepatitis B vaccine into childhood immunization services [06/22/2012]; Available from:. http://whqlibdoc.who.int/hq/2001/WHO_V&B_01.31.pdf.
36. Department of Veterans Affairs Office of Inspector General Oversight review of dental clinic issues, Dayton VA Medical Center, Dayton, Ohio 2011.
37. Department of Veterans Affairs Office of Inspector General Reprocessing of dental instruments John Cochran Division of St. Louis VA Medical Center, St. Louis, Missouri 2011.
38. Di Stefano M., et al. Occult HBV infection in hemodialysis setting is marked by presence of isolated antibodies to HBcAg and HCV. J Nephrol 2009, 22(3):381-386.
39. Diamantis I.D., et al. Polymerase chain reaction detects hepatitis B virus DNA in paraffin-embedded liver tissue from patients sero- and histo-negative for active hepatitis B. Virchows Arch A Pathol Anat Histopathol 1992, 420(1):11-15.
40. Dienstag J.L. Hepatitis B virus infection. N Engl J Med 2008, 359(14):1486-1500.
41. Douglas D.D., et al. Absence of hepatitis B virus DNA detected by polymerase chain reaction in blood donors who are hepatitis B surface antigen negative and antibody to hepatitis B core antigen positive from a United States population with a low prevalence of hepatitis B serologic markers. Transfusion 1993, 33(3):212-216.
42. El-Zaatari M., et al. Hepatitis B virus DNA in serum of "anti-HBc only"-positive healthy Lebanese blood donors: significance and possible implications. J Hosp Infect 2007, 66(3):278-282.
43. Fang Y., et al. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China. J Infect 2009, 58(5):383-388.
44. Fang Z.L., et al. Hepatitis B virus genotypes, phylogeny and occult infection in a region with a high incidence of hepatocellular carcinoma in China. World J Gastroenterol 2004, 10(22):3264-3268.
45. FDA Drug Safety Communication: boxed warning and new recommendations to increase risk of hepatitis B reactivation with the immune-suppressing and anti-cancer drugs Arzerra (ofatumumab) and Rituxan (rituximab) [11/01/13]; Available from:. http://www.fda.gov/DrugSafety/ucm366406.htm.
46. Feray C., et al. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology 1993, 104(2):549-555.
47. Figus A., et al. Hepatitis B viral nucleotide sequences in non-A, non-B or hepatitis B virus-related chronic liver disease. Hepatology 1984, 4(3):364-368.
48. Findik D., Arslan U., Baykan M. Determination of hepatitis B virus DNA incidence, viral load, and mutations in blood donors with HBsAg and anti-HBs-negative serology and antibodies to hepatitis B core antigen. Eur J Intern Med 2007, 18(8):571-575.
49. Fowler M.J., et al. Integration of HBV-DNA may not be a prerequisite for the maintenance of the state of malignant transformation. An analysis of 110 liver biopsies. J Hepatol 1986, 2(2):218-229.
50. Fukuda R., et al. Hepatitis B virus with X gene mutation is associated with the majority of serologically "silent" non-b, non-c chronic hepatitis. Microbiol Immunol 1996, 40(7):481-488.
51. Gandhi M.J., et al. Hepatitis B virions isolated with antibodies to the pre-S1 domain reveal occult viremia by PCR in Alaska Native HBV carriers who have seroconverted. Transfusion 2000, 40(8):910-916.
52. Georgiadou S.P., et al. Occult hepatitis B virus infection in patients with autoimmune liver diseases. Liver Int 2009, 29(3):434-442.
53. Gerlich W.H., et al. HBsAg non-reactive HBV infection in blood donors: transmission and pathogenicity. J Med Virol 2007, 79(S1):S32-S36.
54. Gomes S.A., Yoshida C.F., Niel C. Detection of hepatitis B virus DNA in hepatitis B surface antigen-negative serum by polymerase chain reaction: evaluation of different primer pairs and conditions. Acta Virol 1996, 40(3):133-138.
55. Gonzalez R., et al. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain. Transfusion 2010, 50(1):221-230.
56. Grob P., et al. Serological pattern "anti-HBc alone": report on a workshop. J Med Virol 2000, 62(4):450-455.
57. Gutierrez C., et al. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela. J Med Virol 2004, 73(2):200-207.
58. Gutierrez C., et al. Hepatitis B virus DNA in blood samples positive for antibodies to core antigen and negative for surface antigen. Clin Diagn Lab Immunol 1999, 6(5):768-770.
59. Gwak G.Y., et al. Occult hepatitis B virus infection in chronic hemodialysis patients in Korea. Hepatogastroenterology 2008, 55(86-87):1721-1724.
60. Hada H., et al. State of hepatitis B viral DNA in the liver of patients with hepatocellular carcinoma and chronic liver disease. Liver 1986, 6(4):189-198.
61. Han K.H., et al. Southern-blot analysis and simultaneous in situ detection of hepatitis B virus-associated DNA and antigens in patients with end-stage liver disease. Hepatology 1993, 18(5):1032-1038.
62. Harrison T.J., et al. Hepatitis B virus DNA in the hepatocyte. A series of 160 biopsies. J Hepatol 1986, 2(1):1-10.
63. Heijtink R.A., et al. Detection of HBV-DNA in liver biopsy and serum: its significance in the selection of hepatitis B patients for antiviral therapy. Antiviral Res 1987, 7(6):329-340.
64. Hennig H., et al. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. Blood 2002, 100(7):2637-2641.
65. Hepatitis B vaccines. Wkly Epidemiol Rec 2009, 84(40):405-419.
66. Higashi Y., et al. Correlation of clinical characteristics with detection of hepatitis B virus X gene in liver tissue in HBsAg-negative, and HCV-negative hepatocellular carcinoma patients. Liver 2002, 22(5):374-379.
67. Hollinger F.B., Sood G. Occult hepatitis B virus infection: a covert operation. J Viral Hepat 2010, 17(1):1-15.
68. Horiike N., et al. HBV-DNA hybridization in hepatocellular carcinoma associated with alcohol in Japan. J Med Virol 1989, 28(3):189-192.
69. Hsia C.C., et al. Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America. J Med Virol 2003, 70(1):20-26.
70. Hui C.K., et al. Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area. J Hepatol 2005, 42(6):813-819.
71. Huo T.I., et al. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 1998, 28(1):231-236.
72. Ikeda K., et al. Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study. J Viral Hepat 2009, 16(6):437-443.
73. Imazeki F., et al. Integration of hepatitis B virus DNA in hepatocellular carcinoma. Cancer 1986, 58(5):1055-1060.
74. Ioannou G.N. Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative survey. Ann Intern Med 2011, 154(5):319-328.
75. Izmirli S., et al. The detection of occult HBV infection in patients with HBsAg negative pattern by real-time PCR method. Transfus Apher Sci 2012, 47(3):283-287.
76. Jilg W., et al. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. J Hepatol 1995, 23(1):14-20.
77. Joller-Jemelka H.I., Wicki A.N., Grob P.J. Detection of HBs antigen in "anti-HBc alone" positive sera. J Hepatol 1994, 21(2):269-272.
78. Joukar F., et al. Occult hepatitis B infection in a hemodialysis population in Guilan province, northern Iran. Hemodial Int 2012, 16(2):294-297.
79. Kaminski G., et al. Evidence of occult hepatitis B virus infection among Omani blood donors: a preliminary study. Med Princ Pract 2006, 15(5):368-372.
80. Karayiannis P., et al. Hepatitis B virus DNA in saliva, urine, and seminal fluid of carriers of hepatitis B e antigen. Br Med J (Clin Res Ed) 1985, 290(6485):1853-1855.
81. Kazemi-Shirazi L., Petermann D., Muller C. Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C. J Hepatol 2000, 33(5):785-790.
82. Kidd-Ljunggren K., et al. High levels of hepatitis B virus DNA in body fluids from chronic carriers. J Hosp Infect 2006, 64(4):352-357.
83. Kempinska A., Kwak E.J., Angel J.B. Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature. Clin Infect Dis 2005, 41(9):1277-1282.
84. Khamesipour A., et al. Frequency of hepatitis B virus DNA in anti-HBc positive, HBsAg negative blood donors in Rasht, northern Iran. Transfus Apher Sci 2011, 45(2):195-197.
85. Kleinman S. Laboratory testing of donated blood UptoDate [10/24/2011 2/17/2012]; Available from:. http://www.uptodate.com/contents/laboratory-testing-of-donated-blood.
86. Kleinman S.H., et al. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Transfusion 2005, 45(8):1247-1257.
87. Kondili L.A., et al. Hepatitis B, C and Delta virus infections in Albanian patients with chronic liver disease: evaluation of possible changes during the last 10 years. Eur J Gastroenterol Hepatol 2010, 22(2):167-171.
88. Lai M.E., et al. Hepatitis B virus DNA in the serum of Sardinian blood donors negative for the hepatitis B surface antigen. Blood 1989, 73(1):17-19.
89. Larsen J., Hetland G., Skaug K. Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen-negative hepatitis B virus carrier. Transfusion 1990, 30(5):431-432.
90. Lee D.S., et al. HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: possibility of coinfection in these patients must be considered in HBV-high endemic area. J Gastroenterol Hepatol 1997, 12(12):855-861.
91. Liang T.J., et al. Presence of hepatitis B and C viral genomes in US blood donors as detected by polymerase chain reaction amplification. J Med Virol 1994, 42(2):151-157.
92. Lo Y.M., et al. Geographical variation in prevalence of hepatitis B virus DNA in HBsAg negative patients. J Clin Pathol 1993, 46(4):304-308.
93. Lok A.S., et al. Reactivation of hepatitis B during immunosuppressive therapy: potentially fatal yet preventable. Ann Intern Med 2012, 156(10):743-745.
94. Lugassy C., et al. Sequences of hepatitis B virus DNA in the serum and liver of patients with acute benign and fulminant hepatitis. J Infect Dis 1987, 155(1):64-71.
95. Luo K.X., et al. Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen. J Med Virol 1991, 35(1):55-59.
96. Madonia S., et al. Occult hepatitis B and infliximab-induced HBV reactivation. Inflamm Bowel Dis 2007, 13(4):508-509.
97. Mandell G.B.J., Dolin R. Mandell, Douglas, and Bennett's principles and practice of infectious disease 2010, Churchill, Livingstone, Elsevier, Philadelphia.
98. Manzini P., et al. Italian blood donors with anti-HBc and occult hepatitis B virus infection. Haematologica 2007, 92(12):1664-1670.
99. Marcellin P., et al. Hepatocellular carcinoma with normal adjacent liver. Hepatitis B virus DNA status. J Hepatol 1989, 8(2):249-253.
100. Marusawa H., et al. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology 2000, 31(2):488-495.
101. Mason A., et al. Hepatitis B virus DNA in peripheral-blood mononuclear cells in chronic hepatitis B after HBsAg clearance. Hepatology 1992, 16(1):36-41.
102. Mason A.L., et al. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen. Hepatology 1998, 27(6):1736-1742.
103. Mast E.E., et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 2005, 54(RR-16):1-31.
104. Mast E.E., et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006, 55(RR-16):1-33. [quiz CE1-4].
105. McMahon B.J., et al. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med 2001, 135(9):759-768.
106. Mei S.D., et al. Detection of HBV RNA in peripheral blood mononuclear cells in patients with and without HBsAg by reverse transcription polymerase chain reaction. Hepatol Res 2000, 18(1):19-28.
107. Mina P., et al. Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece. World J Gastroenterol 2010, 16(2):225-231.
108. Minuk G.Y., et al. Occult hepatitis B virus infection in a North American adult hemodialysis patient population. Hepatology 2004, 40(5):1072-1077.
109. Minuk G.Y., et al. Occult hepatitis B virus infection in a North American community-based population. J Hepatol 2005, 42(4):480-485.
110. Mitchell A.E., Colvin H.M., Palmer Beasley R. Institute of Medicine recommendations for the prevention and control of hepatitis B and C. Hepatology 2010, 51(3):729-733.
111. Motta-Castro A.R., et al. Molecular epidemiology of hepatitis B virus in an isolated Afro-Brazilian community. Arch Virol 2008, 153(12):2197-2205.
112. Nagaraju K., et al. High prevalence of HBV infectivity in blood donors detected by the dot blot hybridisation assay. Vox Sang 1994, 67(2):183-186.
113. Nalpas B., Berthelot P., Thiers V. Hepatitis B virus multiplication in the absence of usual serological markers. A study of 146 chronic alcoholics. J Hepatol 1985, 1(2):89-97.
114. Niederhauser C., et al. Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus?. Swiss Med Wkly 2008, 138(9-10):134-141.
115. Noborg U., et al. Levels of viraemia in subjects with serological markers of past or chronic hepatitis B virus infection. Scand J Infect Dis 2000, 32(3):249-252.
116. O'Brien S.F., et al. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience. Transfusion 2007, 47(10):1809-1815.
117. Oesterreicher C., et al. HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. Kidney Int 1995, 48(6):1967-1971.
118. Owiredu W.K., Kramvis A., Kew M.C. Hepatitis B virus DNA in serum of healthy black African adults positive for hepatitis B surface antibody alone: possible association with recombination between genotypes A and D. J Med Virol 2001, 64(4):441-454.
119. Panigrahi R., et al. Anti-hepatitis B core antigen testing with detection and characterization of occult hepatitis B virus by an in-house nucleic acid testing among blood donors in Behrampur, Ganjam, Orissa in southeastern India: implications for transfusion. Virol J 2010, 7:204.
120. Pao C.C., et al. Presence of hepatitis B virus DNA in serum of surface-antigen-seronegative immunocompromised patients. J Clin Microbiol 1987, 25(2):449-451.
121. Pao C.C., et al. Serum hepatitis B virus DNA in hepatitis B virus seropositive and seronegative patients with normal liver function. Am J Clin Pathol 1991, 95(4):591-596.
122. Pasquinelli C., et al. Hepatitis B virus DNA in mononuclear blood cells. A frequent event in hepatitis B surface antigen-positive and -negative patients with acute and chronic liver disease. J Hepatol 1986, 3(1):95-103.
123. Paterlini P., et al. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area. Hepatology 1993, 17(1):20-29.
124. Paterlini P., Brechot C. The detection of hepatitis B virus (HBV) in HBsAG negative individuals with primary liver cancer. Dig Dis Sci 1991, 36(8):1122-1129.
125. Paterlini P., et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990, 323(2):80-85.
126. Picardi M., et al. Clinical relevance of intrahepatic hepatitis B virus DNA in HBsAg-negative Anti-HBc-positive patients undergoing hematopoietic stem cell transplantation for hematological malignancies. Transplantation 2006, 82(1):141-142.
127. Pinho J.R., et al. Detection of hepatitis B virus DNA by the polymerase chain reaction in anti-HBe positive chronic hepatitis B patients. Rev Inst Med Trop Sao Paulo 1993, 35(6):515-520.
128. Pol S., et al. Monoclonal anti-HBs antibodies radioimmunoassay and serum HBV-DNA hybridization as diagnostic tools of HBV infection: relative prevalence among HBsAg-negative alcoholics, patients with chronic hepatitis or hepatocellular carcinomas and blood donors. Eur J Clin Invest 1987, 17(6):515-521.
129. Pollicino T., et al. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 2004, 126(1):102-110.
130. Pontisso P., et al. HBV-DNA sequences are rarely detected in the liver of patients with HBsAg-negative chronic active liver disease and with hepatocellular carcinoma in Italy. Liver 1987, 7(4):211-215.
131. Raimondo G., et al. Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol 2008, 48(5):743-746.
132. Roman S., et al. Occult hepatitis B in the genotype H-infected Nahuas and Huichol native Mexican population. J Med Virol 2010, 82(9):1527-1536.
133. Roque-Afonso A.M., et al. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors. Gut 2002, 50(1):95-99.
134. Roth W.K., et al. NAT for HBV and anti-HBc testing increase blood safety. Transfusion 2002, 42(7):869-875.
135. Said Z.N. An overview of occult hepatitis B virus infection. World J Gastroenterol 2011, 17(15):1927-1938.
136. Sakamoto M., et al. Increasing incidence of hepatocellular carcinoma possibly associated with non-A, non-B hepatitis in Japan, disclosed by hepatitis B virus DNA analysis of surgically resected cases. Cancer Res 1988, 48(24 Pt 1):7294-7297.
137. Sanchez-Quijano A., et al. Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity. J Hepatol 1993, 17(3):288-293.
138. Satoh K., et al. A new method of concentrating hepatitis B virus (HBV) DNA and HBV surface antigen: an application of the method to the detection of occult HBV infection. Vox Sang 2008, 95(3):174-180.
139. Scully L.J., et al. Detection of hepatitis B virus DNA in the serum of Canadian hepatitis B surface antigen negative, anti-HBc positive individuals, using the polymerase chain reaction. J Med Virol 1994, 44(3):293-297.
140. Seremba E., et al. Validity of the rapid strip assay test for detecting HBsAg in patients admitted to hospital in Uganda. J Med Virol 2010, 82(8):1334-1340.
141. Shang G., et al. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China. Transfus Apher Sci 2009, 41(1):3-7.
142. Shih L.N., et al. Serum hepatitis B virus DNA in healthy HBsAg-negative Chinese adults evaluated by polymerase chain reaction. J Med Virol 1990, 32(4):257-260.
143. Shimada S., et al. Analysis of risk factors for hepatocellular carcinoma that is negative for hepatitis B surface antigen (HBsAg). Intern Med 2003, 42(5):389-393.
144. Silva C.M., et al. Low rate of occult hepatitis B virus infection among anti-HBc positive blood donors living in a low prevalence region in Brazil. J Infect 2005, 51(1):24-29.
145. Silva A.E., et al. Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine. Clin Infect Dis 1998, 26(4):895-897.
146. Sun C.F., et al. Screening for hepatitis B virus in healthy blood donors by molecular DNA hybridization analysis. J Clin Microbiol 1988, 26(9):1848-1852.
147. Tassopoulos N.C., et al. Search for hepatitis B virus DNA in sera from patients with acute type B or non-A, non-B hepatitis. J Hepatol 1986, 2(3):410-418.
148. Thedja M.D., et al. Occult hepatitis B in blood donors in Indonesia: altered antigenicity of the hepatitis B virus surface protein. Hepatol Int 2010, 4(3):608-614.
149. Thijssen E.J., et al. The significance of complete serological testing for hepatitis B in heart valve banking. Transplantation 1993, 56(1):82-84.
150. Tokeshi S., Sata M., Tanikawa K. Detection of serum HBV DNA and anti-HCV antibody in HBsAg seronegative patients with hepatocellular carcinoma in Japan. Kansenshogaku Zasshi 1996, 70(2):103-107.
151. Toyoda H., et al. Prevalence of low-level hepatitis B viremia in patients with HBV surface antigen-negative hepatocellular carcinoma with and without hepatitis C virus infection in Japan: analysis by COBAS TaqMan real-time PCR. Intervirology 2007, 50(4):241-244.
152. Umeda M., et al. Hepatitis B virus infection in lymphatic tissues in inactive hepatitis B carriers. J Hepatol 2005, 42(6):806-812.
153. US Department of Health and Human Services Combating the silent epidemic of viral hepatitis: action plan for the prevention, care & treatment of viral hepatitis [6/1/2012]; Available from:. http://www.hhs.gov/ash/initiatives/hepatitis/actionplan_viralhepatitis2011.pdf.
154. US Department of Veterans Affairs Screening for hepatitis B [5/25/2012]; Available from:, [NOTE: This is an internal VA Web site not available to the public.]. http://vaww.prevention.va.gov/Screening_for_Hepatitis_B.asp#VHA.
155. US Food and Drug Administration [04/01/11 06/06/12]; Available from:. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?FRE=610.40.
156. Utsumi T., et al. Characteristics of occult hepatitis B virus infection in the Solomon Islands. Int J Mol Med 2011, 27(6):829-834.
157. Vaccine Assessment and Monitoring Team WHO-recommended standards for surveillance of selected vaccine-preventable diseases Available from:. http://whqlibdoc.who.int/hq/2003/WHO_V&B_03.01.pdf.
158. Van Ditzhuijsen T.J.M., Yap S.H. Clinical aspects of hepatitis B virus DNA detection. Scand J Gastroenterol Suppl 1989, 24(171):57-68.
159. von Weizsacker F., Blum H.E., Wands J.R. Polymerase chain reaction analysis of hepatitis B virus DNA in formalin-fixed, paraffin-embedded liver biopsies from alcoholics using a simplified and standardized amplification protocol. J Hepatol 1994, 20(5):646-649.
160. Walz A., et al. Vertical transmission of hepatitis B virus (HBV) from mothers negative for HBV surface antigen and positive for antibody to HBV core antigen. J Infect Dis 2009, 200(8):1227-1231.
161. Wang J.T., et al. Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen. J Infect Dis 1991, 163(2):397-399.
162. Weber B., et al. Hepatitis B virus markers in anti-HBc only positive individuals. J Med Virol 2001, 64(3):312-319.
163. Weinbaum C.M., et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 2008, 57(RR-8):1-20.
164. White Y.S., et al. Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers. Br J Cancer 1990, 61(6):909-912.
165. World Health Organization (WHO) [12/4/12]; Available from:. http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/index3.html#prevalence.
166. Yokosuka O., et al. Detection and direct sequencing of hepatitis B virus genome by DNA amplification method. Gastroenterology 1991, 100(1):175-181.
167. Yoshiba M., et al. Post-transfusion fulminant hepatitis B after screening for hepatitis B virus core antibody. Lancet 1992, 339(8787):253-254.
168. Yotsuyanagi H., et al. Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors. Transfusion 2001, 41(9):1093-1099.
169. Zervou E.K., et al. Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece. Transfusion 2001, 41(5):652-658.
170. Zhang Y.Y., Yu Z.Q., Hao L.J. Analysis of intrahepatic HBV DNA in serologic HBV markers-negative or HBsAg-negative patients with chronic hepatitis. J Tongji Med Univ 1992, 12(1):43-47.
171. Zhang Y.Y., et al. Hepatitis B virus DNA detected by PCR in sera and liver tissues of Chinese patients with chronic liver diseases. Chin Med J (Engl) 1993, 106(1):7-12.
172. Zheng X., et al. Characterization of occult hepatitis B virus infection from blood donors in China. J Clin Microbiol 2011, 49(5):1730-1737.
173. Zignego A.L., et al. "Inapparent" hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease. Hepatology 1994, 19(3):577-582.